Ignite Creation Date:
2024-05-05 @ 9:25 PM
Last Modification Date:
2024-10-26 @ 10:04 AM
Study NCT ID:
NCT00883298
Status:
COMPLETED
Last Update Posted:
2017-03-30
First Post:
2009-04-16
Brief Title:
Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
Sponsor:
Organization:
Center for Neurosciences Tucson